| The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model M van der Gaag, T Hoffman, M Remijsen, R Hijman, L de Haan, ... Schizophrenia research 85 (1-3), 280-287, 2006 | 613 | 2006 |
| Acute dystonia induced by drug treatment PN van Harten, HW Hoek, RS Kahn Bmj 319 (7210), 623-626, 1999 | 281 | 1999 |
| The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions M van der Gaag, A Cuijpers, T Hoffman, M Remijsen, R Hijman, ... Schizophrenia research 85 (1-3), 273-279, 2006 | 217 | 2006 |
| Antipsychotic-induced tardive dyskinesia and polymorphic variations in COMT, DRD2, CYP1A2 and MnSOD genes: a meta-analysis of pharmacogenetic interactions PR Bakker, PN Van Harten, J Van Os Molecular psychiatry 13 (5), 544-556, 2008 | 180 | 2008 |
| The incidence of anorexia nervosa on Curacao HW Hoek, PN van Harten, KME Hermans, MA Katzman, GE Matroos, ... American Journal of Psychiatry 162 (4), 748-752, 2005 | 167 | 2005 |
| Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis PR Bakker, PN van Harten, J van Os Schizophrenia research 83 (2-3), 185-192, 2006 | 157 | 2006 |
| The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curacao Extrapyramidal Syndromes Study: I PN van Harten, GE Matroos, HW Hoek, RS Kahn Schizophrenia research 19 (2-3), 195-203, 1996 | 149 | 1996 |
| Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis JPF Koning, DE Tenback, J van Os, A Aleman, RS Kahn, PN van Harten Schizophrenia bulletin 36 (4), 723-731, 2010 | 130 | 2010 |
| Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects Y Roke, PN van Harten, AM Boot, JK Buitelaar Journal of child and adolescent psychopharmacology 19 (4), 403-414, 2009 | 126 | 2009 |
| Tardive dystonia PN van Harten, RS Kahn Schizophrenia bulletin 25 (4), 741-748, 1999 | 120 | 1999 |
| Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curacao Extrapyramidal Syndromes Study III PN van Harten, HW Hoek, GE Matroos, M Koeter, RS Kahn American Journal of Psychiatry 155 (4), 565-567, 1998 | 98 | 1998 |
| Evidence that early extrapyramidal symptoms predict later tardive dyskinesia: a prospective analysis of 10,000 patients in the European Schizophrenia Outpatient Health Outcomes … DE Tenback, PN Van Harten, CJ Slooff, J Van Os, SOHO Study Group American Journal of Psychiatry 163 (8), 1438-1440, 2006 | 97 | 2006 |
| Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study WJ Broekema, IW De Groot, PN Van Harten Pharmacy world & science 29, 126-130, 2007 | 90 | 2007 |
| The clinical and prognostic value of motor abnormalities in psychosis, and the importance of instrumental assessment PN van Harten, S Walther, JS Kent, SR Sponheim, VA Mittal Neuroscience & Biobehavioral Reviews 80, 476-487, 2017 | 89 | 2017 |
| Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study DE Tenback, PN van Harten, CJ Slooff, MA Belger, J van Os Journal of Clinical Psychiatry 66 (9), 1130-1133, 2005 | 86 | 2005 |
| Cocaine as a risk factor for neuroleptic-induced acute dystonia PN Van Harten, J Van Trier, EH Horwitz, GE Matroos, HW Hoek Journal of Clinical Psychiatry 59 (3), 128-130, 1998 | 86 | 1998 |
| Non‐therapeutic risk factors for onset of tardive dyskinesia in schizophrenia: a meta‐analysis DE Tenback, PN van Harten, J van Os Movement disorders 24 (16), 2309-2315, 2009 | 85 | 2009 |
| Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19 AB Koopmans, MH Braakman, DJ Vinkers, HW Hoek, PN van Harten Translational psychiatry 11 (1), 141, 2021 | 77 | 2021 |
| Long-stay psychiatric patients: a prospective study revealing persistent antipsychotic-induced movement disorder PR Bakker, IW de Groot, J van Os, PN van Harten PloS one 6 (10), e25588, 2011 | 76 | 2011 |
| Addition of risperidone to clozapine therapy in chronically psychotic inpatients. IW de Groot, AH Heck, PN van Harten Physicians Postgraduate Press, 2001 | 73 | 2001 |
